About US
Contact us
-
Pfizer to buy FoldRx PharmaPfizer is set to acquire drug discovery and clinical development company FoldRx Pharmaceuticals under an agreement signed between the companies. FoldRx is engaged in clinical and pre-clinical program2010/9/3
-
Merck, Cardiome Pharma receive European approval for BrinavessMerck (known as MSD outside the US and Canada) and Cardiome Pharma's intravenous (IV) formulation of Brinavess (vernakalant) has received marketing approval in the EU, Iceland and Norway. Brinavess2010/9/3
-
pSivida announces FDA Priority Review status for Iluvien NDApSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alim2010/9/2
-
EDIMS licenses First DataBank's National Drug Data File Plus databaseFirst DataBank, a leading provider of drug databases that help drive patient safety, and EDIMS, a leading provider of interoperable emergency department (ED) information management systems, today anno2010/9/2
-
Fifty years of propionic acid manufacturing at BASF· Versatile intermediate · Eco-efficient feed preservative A rather acidic success story started at BASF 50 years ago: in the summer of 1960, the company brought on stream the first large-scale2010/9/1
-
Work Standards on Sampling Test for Food Safety Supervision in Catering Services issuedIn order to strengthen the supervision over the food safety in catering services and standardize the work of sampling test, the State Food and Drug Administration recently issued the Work Standards on2010/9/1
-
Eisai receives new action date for FDA priority review of eribulin mesylate NDA for metastatic breast cancerEisai Inc. announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency expects to complete priority review of the eribulin mesylate New Drug Appl2010/8/31
-
Research on clopidogrel reports complexity to FDA black box warningNew findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix. After res2010/8/31
-
Ricerca Biosciences completes purification of an API under cGMP controlsRicerca Biosciences, a uniquely integrated preclinical contract research organization (CRO) providing services to the biopharmaceutical industry, is pleased to announce the successful completion of th2010/8/30
-
FDA approves Novartis' Tekamlo for treatment of high blood pressureThe US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin in2010/8/30